Gerber Kawasaki Wealth & Investment Management Sells 645 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Gerber Kawasaki Wealth & Investment Management trimmed its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 4.8% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 12,919 shares of the exchange traded fund’s stock after selling 645 shares during the period. Gerber Kawasaki Wealth & Investment Management’s holdings in SPDR S&P Biotech ETF were worth $1,164,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Demars Financial Group LLC bought a new stake in SPDR S&P Biotech ETF in the fourth quarter worth $280,309,000. Mirae Asset Securities USA Inc. increased its holdings in shares of SPDR S&P Biotech ETF by 66.7% during the 4th quarter. Mirae Asset Securities USA Inc. now owns 1,500,000 shares of the exchange traded fund’s stock valued at $135,090,000 after acquiring an additional 600,000 shares during the last quarter. Bessemer Group Inc. raised its stake in shares of SPDR S&P Biotech ETF by 5.7% in the 4th quarter. Bessemer Group Inc. now owns 1,376,834 shares of the exchange traded fund’s stock valued at $123,997,000 after acquiring an additional 73,866 shares in the last quarter. Proficio Capital Partners LLC lifted its holdings in SPDR S&P Biotech ETF by 16,156.1% in the 4th quarter. Proficio Capital Partners LLC now owns 917,329 shares of the exchange traded fund’s stock worth $82,615,000 after purchasing an additional 911,686 shares during the last quarter. Finally, Employees Retirement System of Texas boosted its position in SPDR S&P Biotech ETF by 33.6% during the fourth quarter. Employees Retirement System of Texas now owns 877,272 shares of the exchange traded fund’s stock worth $79,007,000 after purchasing an additional 220,400 shares during the period.

SPDR S&P Biotech ETF Stock Down 0.8 %

NYSEARCA:XBI opened at $80.25 on Friday. The company’s 50 day moving average is $82.53 and its 200-day moving average is $90.48. SPDR S&P Biotech ETF has a 12 month low of $66.66 and a 12 month high of $105.47. The firm has a market cap of $5.10 billion, a price-to-earnings ratio of 11.47 and a beta of 1.00.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.